Loading...
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8(+) T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Tumor-reactive T cell exhaustion prevents the success of immune therapies. Pegilodecakin activates intratumoral CD8(+) T cells in mice and induces objective tumor responses in patients. Here we report that pegilodecakin induces hallmarks of CD8(+) T cell immunity in cancer patients, including elevat...
Na minha lista:
| Udgivet i: | Cancer Cell |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098754/ https://ncbi.nlm.nih.gov/pubmed/30423297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2018.10.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|